Their stock has not done that well this past year and I would think this is the kind of question disgruntled shareholders would ask of management. Why rollout GV now?
I tried to find a list of all the generic drugs they sell and their respective sales volumes, just to see where GV fell in relation to the others, but haven’t had any luck.
Market Data 
Markets 
AI
